Monoaminergic signaling during mammalian NREM sleep - Recent insights and next-level questions DOI Creative Commons
Georgios Foustoukos, Georgios Foustoukos

Current Opinion in Neurobiology, Год журнала: 2025, Номер 92, С. 103025 - 103025

Опубликована: Апрель 22, 2025

Язык: Английский

Noradrenergic system in the pathogenesis of age-dependent neurodegeneration DOI
Robert Zorec

Ageing & Longevity, Год журнала: 2025, Номер 1.2025, С. 28 - 34

Опубликована: Янв. 28, 2025

Ageing is a key factor in the development of cognitive decline and neurodegeneration, including Alzheimer’s disease (AD), most common form dementia diagnosed. In 2023 US Federal Drug Administration (FDA) approved new drug (Lecanemab, Leqembi) to treat AD that very moderately slows down early-stage (van Dyck et al., 2023). Donanemab (Kisunla, Eli Lilley), acting similarly lecanemab, was by FDA 2024 US, but not yet European Medicines Agency (EMA) EU. The mechanism action both these monoclonal antibodies similar aducanumab (Aduhelm), conditionally for 2021 (but subsequently discontinued producer), on reducing β-amyloid deposits (Sevigny 2016; van However, trials all revealed significant adverse events (brain swelling or brain bleeding); hence treatment neurodegeneration general remains an important unmet medical need, affecting millions people worldwide. Here I discuss role noradrenergic system innervating spinal cord, consisting nucleus locus coeruleus (LC), which appears be vulnerable structure central nervous (CNS) ageing-related factors, leading early LC demise impairments. Therefore, propose understanding noradrenaline cells, particular astrocytes, homeostasis-providing exhibit high density adrenergic receptors, future strategy develop drugs mitigate decline. Keywords: ageing; noradrenaline; adrenoceptors; coeruleus; neuroglia, astrocytes

Язык: Английский

Процитировано

1

Fleeting sleep interruptions may help brain reset DOI
Shaena Montanari

The Transmitter, Год журнала: 2025, Номер unknown

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0

Fading Blue: Exploring the Causes of Locus Coeruleus Damage Across the Lifespan DOI Creative Commons
Alessandro Galgani,

Marco Scotto,

Ugo Faraguna

и другие.

Antioxidants, Год журнала: 2025, Номер 14(3), С. 255 - 255

Опубликована: Фев. 22, 2025

Locus Coeruleus (LC) is a brain nucleus that involved in variety of key functions (ranging from attention modulation to sleep-wake cycle regulation, memory encoding); its proper function necessary both during development and for integrity maintenance, at the microscale macroscale level. Due their specific intrinsic extrinsic features, LC cells are considered particularly susceptible damage concerning insults. This explains involvement degenerative diseases not only adults (in context neurodegenerative disease, mainly), but also children relation early hypoxic Down's Syndrome, among others). In this narrative review, we dissect potential mechanisms through which affected different diseases, with special emphasis on high rate activity it subjected oxidative stress associated it. Further research aimed deepening our understanding these needed enable strategies future could slow down degeneration subjects predisposed disorders.

Язык: Английский

Процитировано

0

Sleep on it! DOI Creative Commons
Laurent Sheybani

Brain Communications, Год журнала: 2025, Номер 7(2)

Опубликована: Янв. 1, 2025

Our Associate Editor, Laurent Sheybani, discusses some very old and recent findings on sleep physiology function, hoping to raise further interest publications in the field.

Язык: Английский

Процитировано

0

Monoaminergic signaling during mammalian NREM sleep - Recent insights and next-level questions DOI Creative Commons
Georgios Foustoukos, Georgios Foustoukos

Current Opinion in Neurobiology, Год журнала: 2025, Номер 92, С. 103025 - 103025

Опубликована: Апрель 22, 2025

Язык: Английский

Процитировано

0